Understanding the effects of banning flavored cigars on public health
Modeling the public health impact of a flavored cigar ban
This study is looking at how a federal ban on flavored cigars might change tobacco use and health, especially for Black individuals and those with lower incomes, by tracking different groups of people over time to see how it could affect their smoking habits and health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10934531 on NIH RePORTER |
What this research studies
This research aims to estimate how a federal ban on flavored cigars could impact tobacco use, mortality rates, and health disparities in the United States. By creating a microsimulation model, the study will track individuals who currently use, have used, or may use cigars, cigarettes, and e-cigarettes over time. The model will focus on specific populations, particularly those who are Black or have lower incomes, to assess how the ban could affect their tobacco use behaviors and health outcomes. The research will also involve gathering expert opinions on potential policy scenarios and their effects on tobacco use post-ban.
Who could benefit from this research
Good fit: Ideal candidates for this research include current, former, or potential users of flavored cigars, particularly individuals from marginalized communities.
Not a fit: Patients who do not use tobacco products or are not affected by flavored cigar use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health outcomes by informing policies that reduce tobacco use and health disparities.
How similar studies have performed: Previous research has shown that similar approaches to modeling tobacco use and policy impacts can provide valuable insights, indicating potential success for this study.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Mills, Sarah — Univ of North Carolina Chapel Hill
- Study coordinator: Mills, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.